| 货号 | 中文品名 | CAS No. | 别名 |
| WT-DM-C20570 | Valeroyl Salicylate | 64206-54-8 | 2-Valeryloxybenzoic Acid |
| WT-DM-C20572 | N-Octadecyl-N'-propyl-sulfamide | 925891-74-3 | |
| WT-DM-C20573 | RG3039 | 1005504-62-0 | |
| WT-DM-C20574 | EC 23 | 104561-41-3 | AGN 190205 |
| WT-DM-C20575 | Tpl2 Kinase Inhibitor (hydrochloride) | | |
| WT-DM-C20577 | O-Demethyl Apremilast | 1384441-38-6 | 4'-hydroxy APR |
| WT-DM-C20578 | AVE-1625 | 358970-97-5 | Drinabant |
| WT-DM-C20579 | Eniluracil | 59989-18-3 | 776C85 |
| WT-DM-C20580 | QLT0267 | 866409-68-9 | |
| WT-DM-C20581 | Calcipotriol (hydrate) | 147657-22-5 | Calcipotriene |
| WT-DM-C20582 | Ripretinib | 1442472-39-0 | DCC-2618 |
| WT-DM-C20583 | Belinostat | 866323-14-0 | PXD 101 |
| WT-DM-C20585 | Osilodrostat | 928134-65-0 | LCI699 |
| WT-DM-C20588 | CD532 | 1639009-81-6 | |
| WT-DM-C20592 | (R)-SLV 319 | 656827-86-0 | |
| WT-DM-C20594 | Roflumilast N-oxide | 292135-78-5 | |
| WT-DM-C20598 | (S)-SLV 319 | 464213-10-3 | Ibipinabant |
| WT-DM-C20599 | MRTX-1257 | 2206736-04-9 | |
| WT-DM-C20601 | Bezafibrate | 41859-67-0 | Benzofibrate |
| WT-DM-C20604 | 2,3-bis (4-Hydroxyphenyl) Propionitrile | 1428-67-7 | DPN |
| WT-DM-C20606 | Enarodustat | 1262132-81-9 | JTZ-951 |
| WT-DM-C20609 | Sulfatinib | 1308672-74-3 | HMPL-012 |
| WT-DM-C20610 | Purmorphamine | 483367-10-8 | |
| WT-DM-C20611 | ACU 4429 (hydrochloride) | 1141934-97-5 | |
| WT-DM-C20612 | (+)-N-3-Benzylnirvanol | 790676-40-3 | (S)-N-3-benzyl Nirvanol |
| WT-DM-C20613 | O-2545 (hydrochloride) | 874745-43-4 | |
| WT-DM-C20615 | PCI 45227 | 1654820-87-7 | Dihydrodiol Ibrutinib |
| WT-DM-C20617 | BCI-121 | 432529-82-3 | |
| WT-DM-C20619 | Acebilustat | 943764-99-6 | CTX-4430 |
| WT-DM-C20621 | Savolitinib | 1313725-88-0 | AZD6094 |
| WT-DM-C20623 | Edicotinib | 1142363-52-7 | JNJ-40346527 |
| WT-DM-C20625 | BSH-IN-1 | 2553217-91-5 | |
| WT-DM-C20627 | Ibiglustat | 1401090-53-6 | Genz-682452 |
| WT-DM-C20628 | Propylpyrazole Triol | 263717-53-9 | PPT |
| WT-DM-C20629 | Tegoprazan | 942195-55-3 | CJ-12420 |
| WT-DM-C20630 | Nifenazone | 2139-47-1 | Niapyrin |
| WT-DM-C20633 | NR-160 | 2484895-50-1 | |
| WT-DM-C20636 | DSDP | 1777807-64-3 | ZINC03129319 |
| WT-DM-C20639 | PS-210 | 1221962-86-2 | |
| WT-DM-C20640 | ASTX029 | 2095719-92-7 | |
| WT-DM-C20641 | YF-2 | 1311423-89-8 | |
| WT-DM-C20642 | RBN-2397 | 2381037-82-5 | |
| WT-DM-C20643 | Clinofibrate | 30299-08-2 | S-8527 |
| WT-DM-C20645 | 4-octynyl Itaconate | 2454181-83-8 | Click Tag™ 4-octynyl Itaconate |
| WT-DM-C20648 | BPKDi | 1201673-28-0 | |
| WT-DM-C20649 | M1001 | 874590-32-6 | |
| WT-DM-C20652 | Olomoucine II | 500735-47-7 | |
| WT-DM-C20653 | FMK | 821794-92-7 | Fluoromethyl Ketone |
| WT-DM-C20654 | 2BAct | 2143542-28-1 | |
| WT-DM-C20655 | PKG Drug G1 | 374703-78-3 | |
| WT-DM-C20656 | SBP-7455 | 1884222-74-5 | |
| WT-DM-C20657 | KAS 08 | 203861-20-5 | |
| WT-DM-C20658 | Lanraplenib | 1800046-95-0 | GS-9876 |
| WT-DM-C20661 | C53 | 2259624-71-8 | STING Agonist-12 |
| WT-DM-C20662 | RU-521 | 2262452-06-0 | RU-320521 |
| WT-DM-C20663 | MDK35833 | 1016535-83-3 | |
| WT-DM-C20665 | IP7e | 500164-74-9 | Isoxazolo-pyridinone 7e |
| WT-DM-C20666 | MDK34597 | 371934-59-7 | |
| WT-DM-C20667 | Tucatinib | 937263-43-9 | ARRY-380 |
| WT-DM-C20668 | AST-1306 (tosylate) | 1050500-29-2 | Allitinib |
| WT-DM-C20670 | (S)-CR8 | 1084893-56-0 | |
| WT-DM-C20671 | AES-350 | 847249-57-4 | |
| WT-DM-C20672 | OSI-930 | 728033-96-3 | |
| WT-DM-C20675 | MLi-2 | 1627091-47-7 | |
| WT-DM-C20676 | WNK-IN-11 | 2123489-30-3 | |
| WT-DM-C20677 | Lazertinib | 1903008-80-9 | YH25448 |
| WT-DM-C20681 | RIPA-56 | 1956370-21-0 | |
| WT-DM-C20682 | VLX1570 | 1431280-51-1 | |
| WT-DM-C20683 | Trapidil | 15421-84-8 | Triazolopyrimidine |
| WT-DM-C20684 | EZM2302 | 1628830-21-6 | GSK3359088 |
| WT-DM-C20685 | CM-272 | 1846570-31-7 | |
| WT-DM-C20686 | SLM6031434 (hydrochloride) | 1897379-34-8 | |
| WT-DM-C20688 | Branebrutinib | 1912445-55-6 | BMS-986195 |
| WT-DM-C20689 | BIBX1382 | 196612-93-8 | BIBX 1382 BS |
| WT-DM-C20690 | CY-09 | 1073612-91-5 | |
| WT-DM-C20691 | Tolrestat | 82964-04-3 | AY 27773 |
| WT-DM-C20694 | Pemigatinib | 1513857-77-6 | INCB054828 |
| WT-DM-C20696 | Acemetacin | 53164-05-9 | |
| WT-DM-C20697 | MF438 | 921605-87-0 | |
| WT-DM-C20699 | Toloxatone | 29218-27-7 | Humoryl |
| WT-DM-C20701 | PQR530 | 1927857-61-1 | |
| WT-DM-C20702 | ESI-05 | 5184-64-5 | NSC 116966 |
| WT-DM-C20703 | LEI-401 | 2393840-15-6 | |
| WT-DM-C20704 | Dyngo-4a | 1256493-34-1 | |
| WT-DM-C20705 | ZM 449829 | 4452-06-6 | JAK3 Inhibitor V |
| WT-DM-C20707 | iBET-BD2 | 2474876-09-8 | GSK046 |
| WT-DM-C20708 | Hexylglutathione | 24425-56-7 | S-Hexylglutathione |
| WT-DM-C20709 | UK 356618 | 230961-08-7 | |
| WT-DM-C20711 | GC376 (sodium salt) | 1416992-39-6 | |
| WT-DM-C20713 | HUHS015 | 1453097-13-6 | |
| WT-DM-C20715 | Bisubstrate Inhibitor 78 | 2368247-39-4 | |
| WT-DM-C20718 | BLX3887 | 934758-70-0 | 15-LO-1 Inhibitor 3887 |
| WT-DM-C20719 | Olutasidenib | 1887014-12-1 | FT-2102 |
| WT-DM-C20720 | SCIO 469 | 309913-83-5 | Talmapimod |
| WT-DM-C20721 | SEP-0372814 | 1516895-53-6 | |
| WT-DM-C20723 | K-7174 (hydrochloride) | 191089-60-8 | |
| WT-DM-C20724 | RGB-286638 | 784210-88-4 | |
| WT-DM-C20725 | Omapatrilat | 167305-00-2 | BMS-186716 |
| WT-DM-C20731 | GGTI 2418 | 501010-06-6 | |
| WT-DM-C20732 | 3,3'-((2-Chlorophenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) | 4322-58-1 | |
| WT-DM-C20733 | R1487 (hydrochloride) | 449808-64-4 | |
| WT-DM-C20735 | MT-DADMe-ImmA | 653592-04-2 | Methylthio-DADMe-Immucillin A |
| WT-DM-C20736 | UPF-648 | 213400-34-1 | (±)-DBCC |
| WT-DM-C20739 | Crenigacestat | 1421438-81-4 | LY3039478 |
| WT-DM-C20740 | BIIB068 | 1798787-27-5 | |
| WT-DM-C20741 | Upadacitinib | 1310726-60-3 | ABT-494 |
| WT-DM-C20743 | Trandolaprilat (hydrate) | 951393-55-8 | RU 44403 |
| WT-DM-C20744 | PRGL493 | 2479378-45-3 | |
| WT-DM-C20745 | TMI 1 | 287403-39-8 | |
| WT-DM-C20747 | OGG1-IN-O8 | 350997-39-6 | |
| WT-DM-C20748 | TW9 | 2614417-90-0 | |
| WT-DM-C20750 | Ancymidol | 12771-68-5 | EL 531 |
| WT-DM-C20751 | Talniflumate | 66898-62-2 | BA 7602-06 |
| WT-DM-C20752 | 3-TYP | 120241-79-4 | |
| WT-DM-C20753 | Gosogliptin | 869490-23-3 | PF 734200 |
| WT-DM-C20754 | DO264 | 2301866-59-9 | |
| WT-DM-C20755 | TNO155 | 1801765-04-7 | |
| WT-DM-C20756 | GR148672X | 263890-70-6 | |
| WT-DM-C20757 | G150 | 2369751-30-2 | |
| WT-DM-C20759 | SD 2590 (hydrochloride) | 226395-93-3 | SC-78080 |
| WT-DM-C20761 | NCB-0846 | 1792999-26-8 | |
| WT-DM-C20762 | PRN-1371 | 1802929-43-6 | |
| WT-DM-C20763 | SPI 112 | 1051387-90-6 | |
| WT-DM-C20764 | CPYPP | 310460-39-0 | |
| WT-DM-C20766 | Bisacodyl | 603-50-9 | NSC 614826 |
| WT-DM-C20767 | IRAK Inhibitor 6 | 1042672-97-8 | |
| WT-DM-C20769 | Arginase Inhibitor 1 | 1345808-25-4 | |
| WT-DM-C20770 | PACMA 31 | 1401089-31-3 | |
| WT-DM-C20771 | Pamicogrel | 101001-34-7 | KBT-3022 |
| WT-DM-C20772 | Zofenopril (calcium salt) | 81938-43-4 | SQ 26,911 |
| WT-DM-C20773 | LOXO-292 | 2152628-33-4 | ARRY-192 |
| WT-DM-C20775 | SMI-16a | 587852-28-6 | |
| WT-DM-C20778 | Voruciclib | 1000023-04-0 | |
| WT-DM-C20779 | MW-150 | 1628502-91-9 | MW01-18-150SRM |
| WT-DM-C20780 | (S)-Crizotinib | 1374356-45-2 | |
| WT-DM-C20781 | LDC000067 | 1073485-20-7 | LDC067 |
| WT-DM-C20782 | ASLAN003 | 1035688-66-4 | |
| WT-DM-C20783 | NMS-P715 | 1202055-32-0 | |
| WT-DM-C20784 | E2012 | 870843-42-8 | |
| WT-DM-C20785 | UNC0064-12 | 1430089-64-7 | VEGFR-2-IN-5 |
| WT-DM-C20786 | Itopride (hydrochloride) | 122892-31-3 | |
| WT-DM-C20789 | Zardaverine | 101975-10-4 | |
| WT-DM-C20790 | Belvarafenib | 1446113-23-0 | GDC-5573 |
| WT-DM-C20793 | Telotristat | 1033805-28-5 | LP778902 |
| WT-DM-C20796 | 9c(i472) | 2349374-37-2 | 15-LOX-1 Inhibitor i472 |
| WT-DM-C20797 | AIM 100 | 873305-35-2 | |
| WT-DM-C20798 | DS-1001b | 1898207-64-1 | |
| WT-DM-C20800 | CK-666 | 442633-00-3 | |
| WT-DM-C20801 | Meglutol | 503-49-1 | CB 337 |
| WT-DM-C20802 | C188-9 | 432001-19-9 | |
| WT-DM-C20804 | Pamiparib | 1446261-44-4 | BGB-290 |
| WT-DM-C20805 | LXS-196 | 1874276-76-2 | |
| WT-DM-C20806 | Risdiplam | 1825352-65-5 | RG-7916 |
| WT-DM-C20807 | Heparastatin | 153758-25-9 | SF4 |
| WT-DM-C20808 | Alflutinib (mesylate) | 2130958-55-1 | AST2818 |
| WT-DM-C20809 | Cilazapril | 88768-40-5 | Ro 31-2848 |
| WT-DM-C20811 | ODM-203 | 1430723-35-5 | |
| WT-DM-C20814 | Etodolac Acyl Glucuronide | 79541-43-8 | |
| WT-DM-C20817 | LYS-006 | 1799681-85-8 | |
| WT-DM-C20819 | Icotinib | 610798-31-7 | BPI 2009H |
| WT-DM-C20820 | Dynole 34-2 | 1128165-88-7 | |
| WT-DM-C20821 | LDC-1267 | 1361030-48-9 | |
| WT-DM-C20823 | (S)-O-Desmethyl Naproxen | 52079-10-4 | (S)-6-Desmethyl Naproxen |
| WT-DM-C20824 | SNS-062 analog | 1270014-40-8 | BTK-IN-1 |
| WT-DM-C20825 | CNX-2006 | 1375465-09-0 | |
| WT-DM-C20826 | Opicapone | 923287-50-7 | BIA 9-1067 |
| WT-DM-C20827 | S1RA (hydrochloride) | 1265917-14-3 | E-52862 |
| WT-DM-C20828 | Atreleuton | 154355-76-7 | A-85761.0 |
| WT-DM-C20829 | Fruquintinib | 1194506-26-7 | HMPL-013 |
| WT-DM-C20831 | para-amino-Blebbistatin | 2097734-03-5 | (–)-4'-amino-Blebbistatin |
| WT-DM-C20833 | PDE4B Inhibitor | 2410550-31-9 | KVA-D-88 |
| WT-DM-C20834 | VER-246608 | 1684386-71-7 | |
| WT-DM-C20835 | UK 371804 | 256477-09-5 | |
| WT-DM-C20836 | THZ1-R | 1621523-07-6 | |
| WT-DM-C20838 | KY 05009 | 1228280-29-2 | |
